Analytical Profiles of Drug Substances and Excipients / Edition 1by Harry G. Brittain
Pub. Date: 03/01/1998
Publisher: Elsevier Science
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical… See more details below
Although the official compendia define a drug substance as to identity, purity, strength, and quality, they normally do not provide other physical or chemical data, nor do they list methods of synthesis or pathways of physical or biological degradation and metabolism. Such information is scattered throughout the scientific literature and the files of pharmaceutical laboratories. Analytical Profiles of Drug Substances and Excipients, brings the latest information together in one source.
- Elsevier Science
- Publication date:
- Profiles of Drug Substances, Excipients, and Related Methodology Series
- Product dimensions:
- 1.44(w) x 9.00(h) x 6.00(d)
Table of ContentsPrior to forming the Center for Pharmaceutical Physics, Dr. Brittain was Vice President for Pharmaceutical Development of Discovery Laboratories, Inc. Before that, he served as Director of Pharmaceutical Development at Ohmeda, Inc., and also led a variety of groups within the Analytical R&D department at Bristol-Myers Squibb. Dr. Brittain is a graduate of Queens College (B.S., 1970; M.S. 1972), and of the City University of New York (Ph.D. in physical chemistry, 1975). He was a postdoctoral fellow at the University of Virginia, and has held faculty positions at Ferrum College (Assistant Professor of Chemistry) and Seton Hall University (Associate Professor of Physical and Inorganic Chemistry). He has been Adjunct Professor of Pharmaceutics at Rutgers University, and presently holds a position as Visiting Research Scientist in the Chemistry Department at Lehigh University.
Dr. Brittain has authored approximately 225 research publications and book chapters, and has edited the monographs Physical Characterization of Pharmaceutical Solids, Polymorphism in Pharmaceutical Solids, and Analytical Applications of Circular Dichroism. Dr. Brittain is a member of the editorial boards of Pharmaceutical Research, Journal of Pharmaceutical Sciences, Pharmaceutical Development and Technology PharmSci, Pharmaceutical Technology, Journal of Pharmaceutical and Biomedical Analysis, Saudi Pharmaceutical Journal, Chirality, and Instrumentation Science and Technology. He is also the Editor for the book series Analytical Profiles of Drug Substances and Excipients, and is Chairman of the USP Committee 'Excipients: Substances and Characterization' as a member of the Council of Experts. Dr. Brittain was elected as a Fellow of the American Association of Pharmaceutical Sciences (AAPS) in 1991, and received the AAPS Research Achievement Award in Analysis and Pharmaceutical Quality in 1998.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >